{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5b0fd1107b67904376d520f7/650ac7472dcf2c0011926340?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"UK Property Shares, Avacta, and ECR Minerals with Alan Green","description":"<p>The UK Investor Magazine was thrilled to welcome Alan Green back to the Podcast to discuss a selection of UK shares and the macroeconomic backdrop.</p><p><br></p><p>We discuss:</p><p><br></p><ul><li>Barratt Developments (LON:BDEV)</li><li>Avacta (LON:AVCT)</li><li>ECR Minerals (LON:ECR)</li><li><br></li></ul><p><br></p><p>UK CPI inflation surprisingly fell to 6.7% in the year to August from 6.8% the month before. Expectations were for CPI read of 7%. We explore the consequences for housebuilding shares and the wider FTSE 250.</p><p><br></p><p>Avacta made a landmark announcement yesterday on the clinical trials of their AVA6000 chemotherapy drug. Alan breaks the release down and what to look for in the coming weeks from Avacta.</p><p><br></p><p>We finish with a look at the recent developments at ECR Minerals.</p>","author_name":"UK Investor Magazine"}